Skip to main content

Articles By Jack Cush, MD

RheumNow Podcast square

ACR Award Winners (10.21.2022)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.

Read Article
Prgnancy,outcome

Pregnancy Outcomes with Belimumab

Pregnancy in systemic lupus erythematosus (SLE) is fraught with problems of adverse pregnancy outcomes, more pregnancy loss and birth defects. Now a study of SLE pregnancies exposed to belimumab (BEL) shows and expected rate of pregnancy loss but a variable rate of birth defects.

Read Article
RheumNow Podcast square

Primer on Clinical Trials

In this week's special podcast, Dr. Jack Cush offers a primer on rheumatology clinical trials, answering the question: should you be involved in research and clinical trials in rheumatology?

Read Article
heart,CV,MI.cardia,

Predicting Cardiovascular Events in SLE

A study from the Georgia Lupus Registry shows that systemic lupus erythematosus patients are at greatest risk for cardiovascular disease events between years 2 and 11 after diagnosis and higher in Black people or those with a discoid rash.

Read Article
undifferentiated,arthritis,early,RA

Second Efforts in Treating RA Partial Responders

The results of a treat-to-target (T2T) combination therapy trial in patients with early rheumatoid arthritis (RA) show that if patients fail to respond initially, then a second, more intensified regimen can turn initial nonresponders into responders.

Read Article
pregnancy,embryo,fetal

Good Outcomes with TNF Blocker Use During RA Pregnancies

A prospective cohort study of treatment and pregnancy outcomes in women with RA shows that TNF inhibitor use during pregnancy did not increase the risk of adverse pregnancy outcomes, but instead led to more positive outcomes such as fewer low-birth-weight deliveries.

Read Article
infusion.biologic.jpg

Intravenous Immune Globulin in Dermatomyositis

Few drugs have been studied well in the treatment of dermatomyositis (DM) and only recently has intravenous immune globulin (IVIG) been granted FDA approval for the treatment of DM, based on this pivotal trial.

Read Article
RheumNow Podcast square

RheumNow Podcast – “That’s Not My Name” (10.7.2022)

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in addition to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Read Article
woman,doctor,stress,burnout,headache,HA

Physician Burnout Rising

The NY Times has reported results of a study showing that nearly two-thirds of doctors are experiencing at least one symptom of burnout, with a marked increase since the onset of the pandemic.  These findings suggest that burnout rates amongst US doctors have risen to alarming levels.

Read Article
rheum,salary,2022

Rheumatology Salaries and Career Choices

A recent doximity report shows how rheumatology salaries increase by years in practice.  Their salary estimates are based on Doximity acquired data from over 200,000 physicians, along with publicly-available career and salary data from the U.S. Bureau of Labor Statistics, the U.S.

Read Article
×